AMRN:NASDAQ
Amarin Corporation PLC
$11.51
arrow_upward
+1.68%(+0.19) 1D
Oct 19, 10:59:00 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMRN...
Open
$11.41
High
$11.54
Low
$11.32
Mkt. cap
243.12M
Avg. vol.
62.62K
Volume
13.19K
52-wk high
$20.90
52-wk low
$11.25
EPS
-$1.30
Beta
0.76
Shares outstanding
21.12M
No. of employees
80
Open
$11.41
High
$11.54
Low
$11.32
Mkt. cap
243.12M
Avg. vol.
62.62K
Volume
13.19K
52-wk high
$20.90
52-wk low
$11.25
EPS
-$1.30
Beta
0.76
Shares outstanding
21.12M
No. of employees
80
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 day ago
Amarin Q2 2026 Earnings: $0.04 Per Share Swings to Profit, Beating Estimates by 492% - EBITDA Analysis
Profile
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
About Amarin Corporation PLC
CEO-
Employees80
FoundedMar 1, 1989
HeadquartersDublin, Leinster, Ireland
SectorBiotechnology
Websiteamarincorp.com